How OJ: Difference between revisions
From Bioblast
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{Person | {{Person | ||
|lastname=How | |lastname=How | ||
|firstname=Ole-Jakob | |firstname=Ole-Jakob | ||
|title=Dr. | |title=Dr. | ||
|country=Norway | |||
}} | }} | ||
{{Labelingperson}} | |||
{{MitoGlobal EAGLE}} |
Revision as of 11:44, 30 May 2016
Name | How Ole-Jakob, Dr. |
---|---|
Institution | |
Address | , |
City | |
State/Province | |
Country | Norway |
[email protected] | |
Weblink | |
O2k-Network Lab | NO Tromsoe Larsen TS |
Labels:
Publications
Published | Reference | |
---|---|---|
Stenberg 2014 PLoS One | 2014 | Stenberg TA, Kildal AB, Sanden E, How OJ, Hagve M, Ytrehus K, Larsen TS, Myrmel T (2014) The acute phase of experimental cardiogenic shock is counteracted by microcirculatory and mitochondrial adaptations. PLoS One 9:e105213. |